The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies

Yang Yang; Usama Gergis; Matthew Carabasi; Joanne Filicko-O’Hara; John Wagner; William J. O’Hara; Adam Binder; Onder Alpdogan; Ubaldo Martinez-Outschoorn; Pierluigi Porcu; Neal Flomenberg; Dolores Grosso

doi:10.1016/s2666-6367(21)00539-x

The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00539-x ◽

2021 ◽

Vol 27 (3) ◽

pp. S419

Author(s):

Yang Yang ◽

Usama Gergis ◽

Matthew Carabasi ◽

Joanne Filicko-O’Hara ◽

John Wagner ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Lymphoid Malignancies

Download Full-text

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

Leukemia & Lymphoma ◽

10.3109/10428194.2014.894185 ◽

2014 ◽

Vol 55 (12) ◽

pp. 2739-2747 ◽

Cited By ~ 6

Author(s):

Craig S. Sauter ◽

Joanne F. Chou ◽

Esperanza B. Papadopoulos ◽

Miguel-Angel Perales ◽

Ann A. Jakubowski ◽

...

Keyword(s):

Stem Cell ◽

Prospective Study ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Lymphoid Malignancies ◽

Poor Risk ◽

Transplant Program ◽

A Prospective Study ◽

Reduced Intensity

Download Full-text

Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies

Bone Marrow Transplantation ◽

10.1038/s41409-021-01525-1 ◽

2021 ◽

Author(s):

Nobuhiko Imahashi ◽

Seitaro Terakura ◽

Eisei Kondo ◽

Koji Kato ◽

Sung-Won Kim ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Reduced Intensity Conditioning ◽

Lymphoid Malignancies ◽

Reduced Intensity

Download Full-text

The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.12.013 ◽

2021 ◽

Author(s):

Yang Yang ◽

Usama Gergis ◽

Matthew Carabasi ◽

Joanne Filicko-O'Hara ◽

John L. Wagner ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Lymphoid Malignancies

Download Full-text

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.11.029 ◽

2014 ◽

Vol 20 (3) ◽

pp. 354-360 ◽

Cited By ~ 23

Author(s):

Craig S. Sauter ◽

Juliet N. Barker ◽

Lauren Lechner ◽

Junting Zheng ◽

Sean M. Devlin ◽

...

Keyword(s):

Stem Cell ◽

B Cell ◽

Phase Ii ◽

Stem Cell Transplant ◽

Phase Ii Study ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Event Free Survival ◽

Free Survival ◽

Lymphoid Malignancies

Download Full-text

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Zeitschrift für Gastroenterologie ◽

10.1055/s-0037-1612891 ◽

2018 ◽

Vol 56 (01) ◽

pp. E2-E89 ◽

Cited By ~ 1

Author(s):

O Anastasiou ◽

F Almpani ◽

A Herrmann ◽

G Gerken ◽

M Ditschkowski ◽

...

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Hbv Reactivation ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Transplant Recipients

Download Full-text

Management of Allogeneic Stem Cell Transplant Recipients with Hepatic Veno-Occlusive Disease

Global Journal of Hematology and Blood Transfusion ◽

10.15379/2408-9877.2017.04.01.01 ◽

2017 ◽

Vol 4 (1) ◽

Author(s):

Alessandro Busca

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Occlusive Disease ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Transplant Recipients

Download Full-text

APR-246 in Combination With Azacitidine for TP53 Mutated AML or MDS Following Allogeneic Stem Cell Transplant

Case Medical Research ◽

10.31525/ct1-nct03931291 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant

Download Full-text

Clofarabine Pre-allogeneic Stem Cell Transplant for Non-remission AML

Case Medical Research ◽

10.31525/ct1-nct04002115 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant

Download Full-text

Faculty Opinions recommendation of Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718408574.793495760 ◽

2014 ◽

Author(s):

Nelson Chao

Keyword(s):

Stem Cell ◽

Marrow Transplantation ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Blood And Marrow Transplantation ◽

European Group

Download Full-text

T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease

Bone Marrow Transplantation ◽

10.1038/s41409-021-01418-3 ◽

2021 ◽

Author(s):

Thomas E. Lew ◽

Edward R. S. Cliff ◽

Michael Dickinson ◽

Constantine S. Tam ◽

John F. Seymour ◽

...

Keyword(s):

Stem Cell ◽

T Cell ◽

Disease Control ◽

Mantle Cell Lymphoma ◽

Stem Cell Transplant ◽

Cell Lymphoma ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

Mantle Cell

Download Full-text